Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

NCT00337571 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
218
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators